View Financial HealthDeepak Chemtex 配当と自社株買い配当金 基準チェック /06Deepak Chemtex配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.お知らせ • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.お知らせ • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: 544036の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 544036の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Deepak Chemtex 配当利回り対市場544036 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (544036)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Chemicals)0.8%アナリスト予想 (544036) (最長3年)n/a注目すべき配当: 544036は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 544036は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 544036の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 544036が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 06:56終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Deepak Chemtex Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026
New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.
New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.
お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.
お知らせ • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.
New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.
Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.
お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.
Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.
お知らせ • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.
New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.
Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.
Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.